MLNT

Melinta Therapeutics, Inc. Common Stock
MLNT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

MLNT was delisted on the 10th of January, 2020.

Back to rankings

47 hedge funds and large institutions have $9.43M invested in Melinta Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

47% less capital invested

Capital invested by funds: $17.8M → $9.43M (-$8.36M)

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.28M
Puts
$1.22M
Net Calls
Net Calls Change

Top Buyers

1
+$1.29M
2
+$166K
3
+$140K
4
BCM
Bridgeway Capital Management
Texas
+$139K
5
GIM
Granahan Investment Management
Massachusetts
+$69.3K

Top Sellers

1
-$953K
2
-$826K
3
-$607K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$357K
5
Northern Trust
Northern Trust
Illinois
-$208K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$3K
28
$2K
29
$2K
30
$2K
31
$2K
32
$1K
33
$1K
34
$1K
35
$1K
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2